INFARMED — Autoridade Nacional do Medicamento (INFARMED)
INFARMED — Autoridade Nacional do Medicamento is the official source of medicine shortage information for Portugal (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.infarmed.pt
- Country
- Portugal
- Notices tracked by Mederti
- 397
- Last checked
- 24 Sept 2026
Latest notices from INFARMED
- Prasterona — active, medium, since 15 Sept 2026 (source)
- Fluticasona Cipla — active, medium, since 15 Sept 2026 (source)
- Rifabutina — active, medium, since 15 Sept 2026 (source)
- Ácido Valpróico — active, medium, since 15 Sept 2026 (source)
- Alglucosidase Alfa — active, medium, since 15 Sept 2026 (source)
- Roflumilaste — active, medium, since 15 Sept 2026 (source)
- Teriparatida — active, medium, since 15 Sept 2026 (source)
- Sulfametoxazol + Trimetoprim — active, medium, since 15 Sept 2026 (source)
- Alprostadilo — active, medium, since 15 Sept 2026 (source)
- Domperidona Pensa — active, medium, since 15 Sept 2026 (source)
- Rivaroxabano — active, medium, since 15 Sept 2026 (source)
- Atomoxetina — active, medium, since 15 Sept 2026 (source)
- Aztreonam(1 G/Vial) — active, medium, since 15 Sept 2026 (source)
- Isoniazida + Rifampicina — active, medium, since 15 Sept 2026 (source)
- Adenosina — active, medium, since 15 Sept 2026 (source)
Every INFARMED notice, searchable and alertable
Search Portugal's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by INFARMED — Autoridade Nacional do Medicamento. All notices remain the property of their publisher and are linked to the original source.